undefined
EUTM file information

019256847

Ridoxlear


October 5, 2025

Trademark Summary

The trademark application Ridoxlear was filed by Novo Nordisk Health Care AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on November 18, 2025, and still open for oppositions.

The application was filed in Danish (English was selected as the second language).


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations for the treatment of kidney diseases and treatment of liver diseases and pharmaceutical preparations for the treatment of primary hyperoxaluria..